Thesis (PhD) - University of Canberra. / "March 2006" Submitted in accordance with assessment requirements for the Doctor of Philosophy degree of the University of Canberra. Bibliography: p. 228 - 250.

Thesis (M.S.)--Oregon State University, 2007. / Printout. Includes bibliographical references (leaves 81-83). Also available on the World Wide Web.

Thesis (MSc)--University of Stellenbosch, 2006. / Bibliography. Also available via the Internet.

274f. / Submitted by Ana Hilda Fonseca (anahilda@ufba.br) on 2013-04-03T15:45:11Z No. of bitstreams: 1 Tese Vanessa R Guedes.pdf: 23534749 bytes, checksum: df0c04b0207f9bf62a0952e36a12f3f8 (MD5) / Approved for entry into archive by Ana Hilda Fonseca(anahilda@ufba.br) on 2013-04-23T16:58:28Z (GMT) No. of bitstreams: 1 Tese Vanessa R Guedes.pdf: 23534749 bytes, checksum: df0c04b0207f9bf62a0952e36a12f3f8 (MD5) / Made available in DSpace on 2013-04-23T16:58:28Z (GMT). No. of bitstreams: 1 Tese Vanessa R Guedes.pdf: 23534749 bytes, checksum: df0c04b0207f9bf62a0952e36a12f3f8 (MD5) Previous issue date: 2011 / FAPESB e CNPQ / Este trabalho descreve o estudo da atividade antimicrobiana dos extratos e frações obtidos de duas espécies patogênicas ao cacaueiro (Theobroma cacao L.): Moniliophthora perniciosa (vassoura-de-bruxa) e Phytophthora palmivora (podridão parda), além de três espécies antagonistas ao fungo M. perniciosa, sendo elas: Trichoderma stromaticum e dois isolados não identificados pertencentes ao gênero Xylaria que foram nomeadas como Xylaria sp1 e Xylaria sp2. Os extratos e frações estudados foram obtidos a partir do cultivo destas espécies em diferentes meios: líquidos (batata-dextrose, cenoura-dextrose, malte a 2% e Czapek) e sólido (arroz). Neste trabalho, também foi traçado o perfil dos extratos e frações dos fungos na produção de metabólitos secundários, através dos deslocamentos químicos apresentados nos espectros de RMN de 1H e, ainda, foi verificado qual deles se mostrou mais promissor na produção de diferentes metabólitos quando cultivado em diversos meios. Dos extratos em acetato de etila (batata-dextrose) e em metanol (arroz) do fungo Xylaria sp1 foram feitos isolamento, identificação e/ou determinação estrutural de sete metabólitos, através de fracionamentos cromatográficos, utilizando sílica gel e sephadex LH-20 como fase estacionária, e misturas de solventes orgânicos como fase móvel. Desta forma, foram isolados os esteróides: peróxido de ergosterol e ergosterol; dois derivados piridínicos: 3-piridina metanol, o qual seus dados de RMN de 1H e 13C estão sendo relatados pela primeira vez, e o 3-piridina etanol, inédito como produto de origem natural, além de três novos metabólitos secundários, sendo duas lactonas e um ácido carboxílico. As substâncias foram identificadas através das análises de seus espectros de ressonância magnética nuclear de 1H e 13C uni e bidimensionais, por espectrometria de massas e por espectrometria no infravermelho. / Salvador

No description available.

Systemic lupus erythematosus (SLE) is a multi-system autoimmune disease with no known cure. The crosstalk between the gut microbiota and the immune system plays an important role in the tolerance induction to self-antigens both in the intestinal mucosa and at the systemic level. The MRL/lpr mouse model exhibits lupus-like symptoms early in life due to multiple SLE susceptible loci of the MRL background, plus the Faslpr mutation that offers an accelerated model. Recently, we experienced a loss of disease phenotype in our in-house colony compared to the previous published phenotype of MRL/lpr mice. We thus compared mice newly obtained from The Jackson Laboratory (JAX) with our in-house MRL/lpr mice and found that the phenotypic drift, most significantly the attenuation of glomerulonephritis, was present in both colonies. In addition, while JAX mice and mice in our colony are genetically identical, there were minor differences in disease that might be due to differences in splenic microRNAs and the gut microbiota. Once confirming that our MRL/lpr mouse model was as good as that from JAX, we continued our investigation of the role of Lactobacilli in the pathogenesis of lupus-like disease in MRL/lpr mice. We previously published that the mixture of Lactobacillus reuteri (L. reuteri), L. oris, L. johnsonii, L. gasseri, and L. rhamnosus significantly attenuated disease in MRL/lpr mice by restoring the imbalance between regulatory T cells and T helper-17 cells. To further understand the role of Lactobacillus spp., we treated MRL/lpr mice with the combined culture supernatant of the 5 strains containing secreted metabolites, given that the metabolites may induce an immunosuppressive response. The results showed significant attenuation of the inflammation of the spleen and renal lymph nodes similar to the effect of the bacteria themselves. There was also a trending decrease of double-stranded DNA autoantibodies with the combined supernatant. We thus tested the strains individually but none was able to recapitulate the effect of the bacterial mixture. This suggests cell-to-cell contact among different strains of lactobacilli may be required in ameliorating the disease. With these results, we now have a better understanding of the role of probiotic Lactobacillus spp. against SLE. Future investigations will focus on the potential therapeutic effect of Lactobacillus spp. as a combination. Additionally, our group generated a Cx3cr1-deficient MRL/lpr mouse which exhibits a distinct phenotype of exacerbated glomerulonephritis with concurrent change of the gut microbiota composition compared to Cx3cr1+/+ MRL/lpr littermates. Interestingly, upon correction of the gut microbiota with Lactobacillus administration, the phenotype of exacerbated glomerulonephritis was reversed, suggesting that CX3CR1 controls glomerulonephritis in MRL/lpr mice through a gut microbiota-dependent mechanism. In addition, a collaborative project revealed that Cx3cr1 deficiency-mediated pathogenic mechanisms also contributed to SLE-associated cardiovascular disease in MRL/lpr mice. The results of these studies will lead to the identification of new therapeutic targets for the treatment of two severe manifestations, glomerulonephritis and cardiovascular disease, that together account for most of the morbidity and mortality in SLE. / Doctor of Philosophy / Systemic lupus erythematosus (SLE) is an autoimmune disease with no known cure. Commensal microbiota, mostly bacteria living in our gut, and the immune system have a strong relationship in maintaining a healthy state of the gut as well as the whole body. Alterations in the gut microbiota, known as dysbiosis, can facilitate SLE in human and animal models. Current treatments for SLE are primarily focused on using immunosuppressants, but the side effects are still a concern. The use of long-term nonselective immunosuppressant conducts a higher incidence of severe infections in SLE patients. It is thus necessary to develop new approaches and treatments against SLE. My dissertation research is focused on understanding how commensal bacteria influence in the pathogenesis of SLE. My studies have shown that environmental factors can manipulate the gut microbiota leading to different disease outcomes. In addition, following upon previously published studies from our laboratory, I have delineated the mechanism how a mixture of probiotic Lactobacilli can exert a beneficial effect against lupus. Finally, I have revealed a new, CX3CR1-mediated mechanism through which the gut microbiota controls kidney disease in the MRL/lpr lupus-prone mouse model.

Performance of a three-phase fluidized-bed biofilm fermenter system, which is used for the production of a secondary metabolite, is analyzed through computer simulation techniques. Penicillin fermentation was chosen for the model system. From the steady-state analysis, it was found that a complete-mixed contacting pattern is superior to a plug flow pattern in terms of productivity, since less inhibitory effect of the substrate is pronounced in that configuration. Optimum biofilm thickness for the fermenter system was found to be a function of various operating parameters, and should be determined from information on the interactions between fermenter productivity and the operating conditions. The dynamic analysis has shown that for a given constant oxygen transfer rate in bulk phase, there exist operating conditions optimal for maximizing the volumetric productivity of the fermenter system. When a constant oxygen transfer rate with a k.e.a of 300 hr 1 was used with a complete-mixed contacting pattern, the optimum inlet substrate con- centration and mean residence time were found to be 20 (g glucose/liter) and 10 (hours), respectively. Production phase could be extended by increasing the substrate concentration in the feed stream, but the optimum increasing rate and initiation time of increase are functions of other operating parameters, such as initial inlet substrate concentration, mean residence time, and oxygen transfer rate in the fermentor. An increasing rate of 0.6 g glucose/liter/hr with the initiation time t 0 = 51 was found to be the optimal, for the operating conditions found in the dynamic analysis. The result has also shown that a high total biomass concentration and a high oxygen transfer rate in the fermentor are the most important factors to achieve a high productivity. / Ph. D.

Among the myriad of naturally occurring bioactive compounds are the aminocyclopentitol-containing natural products that represent a family of sugar-derived microbial secondary metabolites, such as the antibiotics pactamycin, allosamidin, and trehazolin. Pactamycin, a structurally unique aminocyclitol antibiotic isolated from Streptomyces pactum, consists of a 5-membered ring aminocyclitol (cyclopentitol) unit, two aromatic rings (6-methylsalicylic acid (6-MSA) and 1-(3-Amino-phenyl)-ethanone or 3-aminoacetophenone) and a 1,1-dimethylurea. It has pronounced antibacterial, antitumor, antiviral, and antiplasmodial activities, but its development as a clinical drug was hampered by its broad cytotoxicity. Efforts to modulate its pharmacological and toxicity properties by structural modifications using synthetic organic chemistry have been difficult due to the complexity of its chemical structure. As part of our ongoing studies on the biosynthesis of aminocyclitol-derived bioactive natural products, we have identified the biosynthetic gene cluster of pactamycin in S. pactum ATCC 27456, which paves the way for a better understanding of pactamycin biosynthesis and generating novel pactamycin analogs through biosynthetic engineering. Through gene inactivations, feeding experiments, and in vitro enzymatic assay, we studied the biosynthesis of pactamycin, which include the modes of formation of the unique cyclopentitol unit, the 3-aminoacetophenone and the 6-methyl salicylic acid moieties. Armed with the tools needed to genetically engineer target strains of S. pactum, we were able to produce novel analogs of this untapped-class of natural products. TM-026 was generated from a ΔptmH (a radical SAM C-methyltransferase gene) mutant, whereas TM-025 was generated from a ΔptmH/ΔptmQ (a polyketide synthase gene) double knockout mutant. Both compounds show potent antimalarial activity, but lack significant antibacterial activity, and are about 10-30 times less toxic than pactamycin toward mammalian cells. The results suggest that distinct ribosomal binding selectivity or new mechanism(s) of action may be involved in their plasmodial growth inhibition, which may lead to the discovery of new antimalarial drugs and identification of new molecular targets within malarial parasites. TM-035 was also isolated from a ΔptmH mutant. However, we found that TM-035 showed no activity against bacteria, malarial parasites, and most tested mammalian cells, but it has potent growth inhibitory activity against two well-established human head and neck squamous cell carcinomas (SCC025 and SCC104) (IC₅₀ 725 nM) in an in vitro assay. More intriguingly, the compound is significantly less active against human primary epidermal keratinocytes (HPEK), demonstrating an interesting biological phenomenon and outstanding cell type selectivity, which may lead to the development of new anticancer chemotherapy. The production yield of pactamycin and its congeners under laboratory conditions is relatively low. This has hampered both mechanistic and preclinical studies of these promising compounds. To deepen our understanding of pactamycin biosynthesis and engineer mutant strains with improved production yields, we investigated pathway specific regulatory genes, ptmF and ptmE. Based on gene inactivation and RT-PCR studies, we found that the PtmF-PtmE system controls the transcription of the whole biosynthetic gene cluster. The results provide important insight into regulation of pactamycin biosynthesis and will contribute to future studies that aim at engineering high producing strains of S. pactum. / Graduation date: 2012 / Access restricted to the OSU Community at author's request from Feb. 28, 2012 - Feb. 28, 2013

Thesis (MSc (Wine Biotechnology))--University of Stellenbosch, 2006. / The production of premium quality wine is dependant on excellent management of the total wine production value chain. To achieve this we need rapid and reliable analytical tools. Over the last decade Fourier transform infrared (FT-IR) spectroscopy has made a significant contribution to wine research and in the last five years South African institutions have also exploited the use of this technology not only for research, but also in industrial cellars. The FT-IR apparatus is equipped with global calibrations and therefore we first investigated the validity of these for South African conditions. To achieve this new calibration sets for pH, titratable acidity and °Brix were made and compared to the global calibrations with statistical methods. Results obtained between the °Brix calibrations displayed high correlation and the global calibration can therefore be implemented. However, the new TA calibration was more accurate than the global calibration. Results were inconclusive for the new pH calibration sample set and therefore needs to be enlarged before it can be validated as the possibility of being more accurate exists. It was concluded that FT-IR spectroscopy in the simultaneous measurement for °Brix, pH and TA in grape must showed potential for accurate analysis and quality control purposes in an industrial cellar. Rapid analysis of these parameters will lead to higher throughput of grape must samples in the laboratory as well as adhering to good laboratory practices by validation. The importance of correct sample preparation in the laboratory was illustrated when using FT-IR spectroscopy for one-step analysis and adjustments to global calibrations. Results obtained showed that grape parameters such as °Brix, nitrogen content were not influenced by the two sample preparation methods (hand pressed vs. homogenised), but pH, TA, colour index, anthocyanins and polyphenols were influenced. Important key factors were identified in the quality control chain from vineyard to the cellar. Numerous grape loads had an increase in microbial populations after harvesting the vineyard and transport to the weighbridge. Transport is critical especially for the vineyards in the Lutzville area (had the highest yeast population), which are situated the furthest from the cellar. Sauvignon blanc had the highest acetic acid bacteria and lactic acid bacteria populations compared to the other cultivars. Gluconic acid, glycerol and arabitol was highly correlated to each other. High populations of acetic acid bacteria and lactic acid bacteria also had high levels of gluconic acid and 2,3-butanediol in the grape juice. Meso-inositol differed significantly between the vineyard and weighbridge and it had a high standard deviation compared to the mean value of all the samples between the vineyard and weighbridge. Temperature of grape loads delivered to the cellar ranged from 14 to 36ºC, which had a major impact on the grape quality and the resultant wine. It can be concluded for this study that management of the total value chain is of critical importance to ensure that A-grade grapes results in good quality wine that merits the effort of the grape producer.

Le rôle crucial du tractus gastrointestinal dans la pathogenèse et la pathophysiologie des troubles cardiométaboliques (TCM) et du syndrome métabolique (SM) est actuellement bien établi. Plusieurs facteurs, incluant le stress oxydatif (SOx), l'inflammation et la résistance à l'insuline (RI), perturbent l'homéostasie intestinale et causent des TCM. Les polyphénols (PP) ont des effets biologiques bénéfiques dans la prévention de pathologies métaboliques. Cependant, leurs mécanismes d'actions, surtout au niveau de l'axe intestin-foie, ne sont pas bien compris. Par ailleurs, malgré les nombreuses études sur les effets biologiques et la biodisponibilité des PP, il existe encore des zones d’ombres concernant les interactions entre le microbiote intestinal et les PP et les conséquences subséquentes sur la santé intestinale et métabolique. Dans ce travail de recherche, nous favorisons l’axiome selon lequel les PP, notamment ceux de grande taille moléculaire tels que les proanthocyanidines (PACs), pourraient être utile pour combattre les maladies métaboliques grâce à leurs actions antioxydante et anti-inflammatoire. Toutefois, ces actions précitées des PACs dépendraient d’une régulation en amont du microbiote intestinal. L’objectif central consiste à démontrer les effets bénéfiques des PACs dans la prévention des dérèglements métaboliques dans deux modèles distincts, l’un cellulaire et l’autre animal et d’en étudier les mécanismes. Les effets des PACs sur la RI, les dérangements métaboliques intestinaux grâce à la production de métabolites ont été étudiés. Dans une première étape, nous avons étudié les mécanismes d’actions des PACs et de l’un de leurs métabolites majeurs, le 4,5-dihydroxyphenyl valerolactone (DHPVL), dans la prévention des maladies métaboliques et dans le maintien de l’homéostasie intestinale en utilisant la lignée cellulaire intestinale Caco-2/15. Ces cellules constituent un outil de choix pour l’investigation du SOx, la défense antioxydante et l’inflammation en relation directe avec nos objectifs. Les résultats suggèrent que la capacité des PACs à augmenter la défense antioxydante et anti-inflammatoire et à améliorer l’homéostasie intestinale passeraient en partie probablement par leurs métabolites microbiens. Dans une deuxième étape, en utilisant le modèle murin C57BL6, nous avons déterminé l’impact des PACs sur l’homéostasie métabolique intestinale et hépatique, via l’atténuation du SOx et l’inflammation, le maintien de l’intégrité de la barrière intestinale, la prévention de l’endotoxémie métabolique et les modifications du profil lipidique et de la fonction du microbiote intestinal. Cette partie a évalué les aspects préventifs et thérapeutiques des PACs en spécifiant leurs bénéfices biologiques et voies mécanistiques dans des organes métaboliques clés. Pour étudier ces mécanismes et les comprendre, nous avons utilisé le modèle dysmétabolique de souris C57BL6 soumises à une diète riche en lipides et en sucrose (HFHS), servant à développer le SM et les complications cardio-métaboliques afin d’examiner l’action des PACs. Le développement de l’obésité, de la RI ainsi que la survenue d’autres altérations métaboliques ont été prévenus par l’administration de PACs. Les résultats de cette thèse permettent une meilleure compréhension des mécanismes d’actions qui sous-tendent les effets préventifs et thérapeutiques des PACs dans les désordres métaboliques, en particulier dans l’axe intestin-foie. / The crucial role of the gastrointestinal tract in the pathogenesis and pathophysiology of cardiometabolic disorders (CMD) and metabolic syndrome (MetS) is currently recognized. Several factors, including oxidative stress (OxS), inflammation and insulin resistance (IR), disrupt intestinal homeostasis and cause CMD. Polyphenols (PP) have beneficial biological effects in the prevention of metabolic pathologies. However, their mechanisms of action, especially in the gut-liver axis, are not well understood. Moreover, despite numerous studies on the biological effects and bioavailability of PP, there are still grey areas concerning the interactions between the intestinal microbiota and PP and the subsequent consequences for intestinal and metabolic health. In this research work, we promote the axiom that PP, particularly those of large molecular size such as proanthocyanidins (PACs), could be useful in combating metabolic diseases thanks to their antioxidant and anti-inflammatory actions. However, the aforementioned actions of PACs would depend on upstream regulation of the intestinal microbiota. The central objective is to demonstrate the beneficial effects of PACs in preventing metabolic disorders in two distinct models, one cellular and the other animal, and to study the mechanisms involved. The effects of PACs on IR and intestinal metabolic disturbances through metabolite production were studied. In a first step, we investigated the mechanisms of action of PACs and one of their major metabolites, 4,5-dihydroxyphenyl valerolactone (DHPVL), in the prevention of metabolic diseases and in the maintenance of intestinal homeostasis using the Caco-2/15 intestinal cell line. These cells are a tool of choice for investigating OxS, antioxidant defense and inflammation in direct relation to our objectives. The results suggest that the ability of PACs to enhance antioxidant and anti-inflammatory defense and improve intestinal homeostasis is probably partly mediated by their microbial metabolites. In a second step, using the C57BL6 mouse model, we determined the impact of PACs on intestinal and hepatic metabolic homeostasis, via attenuation of OxS and inflammation, maintenance of intestinal barrier integrity, prevention of metabolic endotoxemia and changes in lipid profile and gut microbiota function. This section assessed the preventive and therapeutic aspects of PACs, specifying their biological benefits and mechanistic pathways in key metabolic organs. To investigate and understand these mechanisms, we used the dysmetabolic model of C57BL6 mice subjected to a high-fat, high-sucrose diet (HFHS), used to develop MetS and cardio-metabolic complications to examine the action of PACs. The development of obesity, IR and other metabolic alterations was prevented by the administration of PACs. The results of this thesis provide a better understanding of the mechanisms of action underlying the preventive and therapeutic effects of PACs in metabolic disorders, particularly in the intestine-liver axis.